VERPA
NVO

Virginia Estate & Retirement Planning Advisors’s Novo Nordisk NVO Stock Holding History

Virginia Estate & Retirement Planning Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5K Hold
73
– – ﹤0.01% 157
2026
Q1 		$2.68K Buy
+73
New +$3.46K ﹤0.01% 139

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Virginia Estate & Retirement Planning Advisors's NVO Position: Q2 2026 in Review

Virginia Estate & Retirement Planning Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 73 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Virginia Estate & Retirement Planning Advisors first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. 1,338 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Virginia Estate & Retirement Planning Advisors held 73 shares of Novo Nordisk worth $3.5K as of Q2 2026.
  • Virginia Estate & Retirement Planning Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Virginia Estate & Retirement Planning Advisors's portfolio in Q2 2026, its #157 holding.
  • Virginia Estate & Retirement Planning Advisors first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Virginia Estate & Retirement Planning Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.